McMillan Shakespeare Ltd
MMS: XASX (AUS)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
A$27.00 | Fmdr | Qpxqvngxv |
Market Sentiment Towards McMillan Shakespeare Improving
McMillan Shakespeare shares have outperformed the benchmark S&P/ASX 200 Index since its interim result in February, rising 5.0% versus the 4.2% market fall. At the interim result, we increased our fair value estimate by 18% to AUD 13 per share, following a change in our valuation methodology. Nonetheless, the shares are now trading broadly in line with fair value.